Trillium Therapeutics Overview

Trillium Therapeutics Research & Development

Research & Development expenses for TRIL.

Quarterly R&D Expenses

$9.93M

↑ 96.69% YoY

As of Sep 30, 2021

Annual R&D Expenses (TTM)

$40.01M

↓ 0.5% YoY

Trailing 12 months ending Sep 30, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin